Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • BCRP
    (2)
  • ABC Transporter
    (1)
  • AChR
    (1)
  • AMPK
    (1)
  • Autophagy
    (1)
  • CDK
    (1)
  • Dopamine Receptor
    (1)
  • Epigenetic Reader Domain
    (1)
  • Histamine Receptor
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (8)
  • Immune System
    (2)
  • Inflammation
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

T1336

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    11
    TargetMol | All_Pathways
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Benztropine mesylate
    Benztropine methanesulfonate, Benzotropine mesylate, Benzatropine mesylate
    T1336132-17-2
    Benztropine mesylate (Benztropine methanesulfonate) is a centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.
    • $29
    In Stock
    Size
    QTY
  • XY101
    T133622349368-16-5In house
    XY101 is a selective, metabolically stable and orally available agonist of RORγ inverse(IC50 of 30 nM and a Kd of 380 nM).
    • $79
    In Stock
    Size
    QTY
  • Y06137
    T133632226534-49-0In house
    Y06137 is an effective and selective BET inhibitor with a Kd of 81 nM for BRD4(1) bromodomain. Y06137 can be used for research on the treatment of castration-resistant prostate cancer.
    • $55
    In Stock
    Size
    QTY
  • YHO-13351 free base
    T13365912288-64-3In house
    YHO-13351 free base, the water-soluble prodrug of YHO-13177, is an inhibitor of BCRP (breast cancer resistance protein).
    • $30
    In Stock
    Size
    QTY
  • XRK3F2
    T133602375193-43-2
    XRK3F2 is an inhibitor of the p62-ZZ domain, blunts MM-induced Runx2 suppression in vitro, and induces new bone formation and remodeling in the presence of tumor in vivo.
    • $34
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • XY028-133
    T133612229974-73-4
    XY028-133 is a PROTAC-based CDK4/6 degrader for the study of tumors.
    • $118
    In Stock
    Size
    QTY
  • YAP/TAZ inhibitor-1
    T133642093565-23-0
    YAP/TAZ inhibitor-1 is a YAP/TAZ inhibitor (IC50 <0.100 μΜ) for the study of abnormal immune function and cancer.
    • $487
    5 days
    Size
    QTY
    TargetMol | Citations Cited
  • YHO-13351
    YHO13351, YHO 13351
    T133661346753-00-1
    YHO-13351 is an ABCG2 inhibitor, an acrylonitrile derivative, that induces sensitization of cancer stem/initiating-like side population cells to irinotecan.GSK1702934A can be used to study diabetes.
    • $30
    In Stock
    Size
    QTY
  • YKL-5-124 TFA (1957203-01-8 free base)
    YKL-5-124 TFA
    T13367
    YKL-5-124 TFA is a potent, selective, irreversible and covalent inhibitor of CDK7 (IC50s of 53.5 nM and 9.7 nM for CDK7 and CDK7/Mat1/CycH, respectively).
    • $1,670
    8-10 weeks
    Size
    QTY
  • YLF-466D
    C24
    T133681273323-67-3
    YLF-466D (C24) is a novel AMPK activator that inhibits platelet aggregation.
    • $31
    In Stock
    Size
    QTY
  • YM-264
    T13369131888-54-5
    YM-264 is a selective and orally active antagonist of platelet-activating factor (PAF) (pKi value of 8.85 for rabbit platelet membranes).
    • $1,520
    6-8 weeks
    Size
    QTY